首页> 美国卫生研究院文献>Aging Cell >Lifespan-extending caloric restriction or mTOR inhibition impair adaptive immunity of old mice by distinct mechanisms
【2h】

Lifespan-extending caloric restriction or mTOR inhibition impair adaptive immunity of old mice by distinct mechanisms

机译:延长寿命的热量限制或mTOR抑制通过不同的机制削弱了老年小鼠的适应性免疫力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Aging of the world population and a concomitant increase in age-related diseases and disabilities mandates the search for strategies to increase healthspan, the length of time an individual lives healthy and productively. Due to the age-related decline of the immune system, infectious diseases remain among the top 5–10 causes of mortality and morbidity in the elderly, and improving immune function during aging remains an important aspect of healthspan extension. Calorie restriction (CR) and more recently rapamycin (rapa) feeding have both been used to extend lifespan in mice. Preciously few studies have actually investigated the impact of each of these interventions upon in vivo immune defense against relevant microbial challenge in old organisms. We tested how rapa and CR each impacted the immune system in adult and old mice. We report that each intervention differentially altered T-cell development in the thymus, peripheral T-cell maintenance, T-cell function and host survival after West Nile virus infection, inducing distinct but deleterious consequences to the aging immune system. We conclude that neither rapa feeding nor CR, in the current form/administration regimen, may be optimal strategies for extending healthy immune function and, with it, lifespan.
机译:世界人口的老龄化以及与年龄有关的疾病和残障的随之而来的增长,迫使人们寻求提高健康水平,延长个人健康和生产性生活时间的战略。由于与年龄有关的免疫系统下降,传染病仍然是老年人死亡和发病的5-10个主要原因,而在衰老过程中改善免疫功能仍然是延长健康寿命的重要方面。热量限制(CR)和最近的雷帕霉素(rapa)喂养均已被用来延长小鼠的寿命。很少有研究真正调查过每种干预措施对体内抵抗旧生物体相关微生物攻击的免疫防御的影响。我们测试了rapa和CR如何分别影响成年和成年小鼠的免疫系统。我们报告说,每项干预措施差异性地改变了胸腺中T细胞的发育,外周T细胞的维持,T细胞的功能和西尼罗河病毒感染后的宿主存活率,对衰老的免疫系统产生了明显但有害的后果。我们得出的结论是,在当前形式/给药方案中,无论是rapa喂养还是CR,都不是延长健康免疫功能及其寿命的最佳策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号